Skip to main content
SpringerLink
Log in

Pharmacology of Acute Lung Injury

  • Conference paper
Book cover Yearbook of Intensive Care and Emergency Medicine 2005

Part of the book series: EN]Yearbook of Intensive Care and Emergency Medicine ((volume 2005))

  • 628 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ware LB, Matthay MA (2002) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349

    Article  Google Scholar 

  2. Hudson LD, Steinberg KP (1999) Epidemiology of acute lung injury and ARDS. Chest 116:74S–82S

    Article  Google Scholar 

  3. McIntyre RC Jr, Pulido EJ, Bensard DD, Shames BD, Abraham E (2000) Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 28:3314–3331

    Article  PubMed  Google Scholar 

  4. Tasaka S, Hasegawa N, Ishizaka A (2002) Pharmacology of acute lung injury. Pulm Pharmacol Ther 15:83–95

    Article  PubMed  Google Scholar 

  5. Reinhart K, Menges T, Gardlund B, et al (2001) Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 29:765–769

    Article  PubMed  Google Scholar 

  6. Panacek E, Marshall J, Fischkoff S, Barchuk W, Teoh L, MONARCS Study Group (2000) Neutralization of TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis: Results of the MONARCS trial. Chest 118:88S (abst)

    Google Scholar 

  7. Pittet D, Harbarth S, Suter PM, et al (1999) Impact of immunomodulating therapy on morbidity in patients with severe sepsis. Am J Respir Crit Care Med 160:852–857

    PubMed  Google Scholar 

  8. Opal SM, Fisher CJ Jr, Dhainaut JF, et al (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial, Crit Care Med 25:1115–1124

    Article  PubMed  Google Scholar 

  9. Fisher CJ Jr, Dhainaut JF, Opal SM, et al (1994) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 271:1836–1843

    Article  PubMed  Google Scholar 

  10. Vedder N, Harlan J, Winn R (1997) Pilot phase 2 clinical trial of a humanized CD11/CD18 monoclonal antibody in hemorrhagic shock. In: Faist E (ed) 4th International Congress on the Immune Consequences of Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches. Mondezzi editore, Bologna, pp 941

    Google Scholar 

  11. Gregory TJ, Steinberg KP, Spragg R, et al (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:1309–1315

    PubMed  Google Scholar 

  12. Kesecioglu JM, Schultz MJ, Lundberg D, Lauven PM, Lachmann B (2001) Treatment of acute lung injury (ALI/ARDS) with surfactant. Am J Respir Crit Care Med 163:A813 (abst)

    Google Scholar 

  13. Wiswell TE, Smith RM, Katz LB, et al (1999) Bronchopulmonary segmental lavage with Surfaxin (KL4-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 160:1188–1395

    PubMed  Google Scholar 

  14. Spragg RG, Lewis JF, Walmrath HD, et al (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome, N Engl J Med 351:884–892

    PubMed  Google Scholar 

  15. Mutlu GM, Sznajder JI (2004) β2-agonists for treatment of pulmonary edema: Ready for clinical studies? Crit Care Med 32:1607–1608

    Article  PubMed  Google Scholar 

  16. Hasegawa N, Oka Y, Nakayama M, et al (1997) The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs. Am J Respir Crit Care Med 155:928–936

    PubMed  Google Scholar 

  17. The ARDS Clinical Trial Network (2002) Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 30:1–6

    Google Scholar 

  18. The ARDS network (2000) Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome. JAMA 283:1995–2002

    Google Scholar 

  19. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K. (1998) Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury, Chest 114:223–228

    PubMed  Google Scholar 

  20. Bindels AJ, van der Hoeven JG Groeneveld PH, Frolich M, Meinders AE (2001) Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndrome. Crit Care 5:151–157

    Article  PubMed  Google Scholar 

  21. Abraham E, Baughman R, Fletcher E, et al (1999) Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 27:1478–1485

    Article  PubMed  Google Scholar 

  22. Meduri GU, Headley AS, Golden E, et al (1998) Effects of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159–165

    Article  PubMed  Google Scholar 

  23. Hasegawa N, Husari AW, Hart WT, Kandra TG, Raffin TA (1994) Role of the coagulation system in ARDS. Chest 105:268–277

    PubMed  Google Scholar 

  24. Laterre PF, Wittebole X, Dhainaut JF (2003) Anticoagulant therapy in acute lung injury. Crit Care Med 31:S329–S336

    Article  PubMed  Google Scholar 

  25. Balk R, Emerson T, Fourrier F, et al (1998) Therapeutic use of antithrombin concentrate in sepsis. Semin Thromb Hemost 24:183–194

    PubMed  Google Scholar 

  26. Eisele B, Lamy M, Thijs LG, et al (1998) Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 24:663–672

    Article  PubMed  Google Scholar 

  27. Bernard GR, Vincent JL, Laterre PF, et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  Google Scholar 

  28. Angus DC, Linde-Zwirble WT Clermont G, et al (2003) Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 31:1–11

    Article  PubMed  Google Scholar 

  29. Tamakuma S, Shiba T, Hiasawa H, Ogawa M, Nakajima M (1998) A phase III clinical study of a neutrophil elastase inhibitor; ENO-5046·Na in SIRS patients. J Clin Ther Med (Japan) 14:289–318

    Google Scholar 

  30. Bellomo R, Uchino S, Naka T, Wan L (2004) Hidden evidence to the West: multicentre, randomised, controlled trials in sepsis and systemic inflammatory response syndrome in Japanese journals. Intensive Care Med 30:911–917

    Article  PubMed  Google Scholar 

  31. Zeiher BG, Artigas A, Vincent JL, et al. (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32:1695–1702

    Article  PubMed  Google Scholar 

Download references

Authors
  1. S. Tasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Ishizaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Tasaka, S., Ishizaka, A. (2005). Pharmacology of Acute Lung Injury. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_8

Download citation

  • DOI: https://doi.org/10.1007/0-387-26272-5_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-23476-0

  • Online ISBN: 978-0-387-26272-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation